|
Dactinomycin for Injection
DEFINITION
Dactinomycin for Injection is a sterile mixture of Dactinomycin and Mannitol. It contains NLT 90.0% and NMT 120.0% of the labeled amount of C62H86N12O16.
[CautionGreat care should be taken to prevent inhaling particles of Dactinomycin and exposing the skin to it.
]
IDENTIFICATION
• A. Procedure
Standard solution:
25 µg/mL of USP Dactinomycin RS in methanol
Sample solution:
25 µg/mL of dactinomycin in methanol
Acceptance criteria:
The UV absorption spectrum of the Sample solution exhibits maxima and minima at the same wavelengths as the Standard solution, concomitantly measured.
Ratio:
A240/A445, 1.301.50
• B.
The retention time of the major peak of the Sample solution corresponds to that of the Standard solution, as obtained in the Assay.
ASSAY
• Procedure
[NoteUse freshly prepared Standard solution and Sample solution, protected from light. ]
Mobile phase:
Acetonitrile and water (3:2)
Standard solution:
250 µg/mL of USP Dactinomycin RS in Mobile phase
Sample solution:
250 µg/mL of dactinomycin from Dactinomycin for Injection diluted with Mobile phase. Filter, if necessary, to obtain a clear solution. [NotePrepare the solution by adding a suitable aliquot of Mobile phase to one container of Dactinomycin for Injection. ]
Chromatographic system
Mode:
LC
Detector:
UV 254 nm
Column:
3.9-mm × 30-cm; packing L1
Flow rate:
2.5 mL/min
Injection size:
10 µL
System suitability
Sample:
Standard solution
[NoteThe retention time for dactinomycin is 6 min. ]
Suitability requirements
Column efficiency:
NLT 1200 theoretical plates
Tailing factor:
NMT 2
Relative standard deviation:
NMT 3.0%
Analysis
Samples:
Standard solution and Sample solution
Calculate the percentage of C62H86N12O16 in the portion of Dactinomycin for Injection taken:
Result = (rU/rS) × (CS/CU) × 100
Acceptance criteria:
90.0%120.0%
SPECIFIC TESTS
• pH
• Loss on Drying
• Other Requirements:
It meets the requirements under Injections
• Bacterial Endotoxins Test
• Sterility Tests
• Constituted Solution:
At the time of use, it meets the requirements for Injections
ADDITIONAL REQUIREMENTS
• Packaging and Storage:
Preserve in light-resistant Containers for Sterile Solids as described under Injections
• Labeling:
Label it to include the statement Protect from light.
Auxiliary Information
Please check for your question in the FAQs before contacting USP.
USP35NF30 Page 2804
Pharmacopeial Forum: Volume No. 35(6) Page 1452
|